Contraceptive Drugs Market
Contraceptive Drugs Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives
- By Age Group 15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years
- By End User Homecare, Hospitals, Clinics
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 12.62 Billion |
Revenue 2030: | USD 18.94 Billion |
Revenue CAGR (2023 - 2030): | 5.20% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Contraceptive Drugs Market Segment Analysis
- Contraceptive Drugs Product Outlook (Revenue, USD Million, 2018 - 2030)
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Contraceptive Drugs Age Group Outlook (Revenue, USD Million, 2018 - 2030)
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Contraceptive Drugs End User Outlook (Revenue, USD Million, 2018 - 2030)
- Homecare
- Hospitals
- Clinics
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
-
North America Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
-
North America Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- U.S.
- U.S. Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- U.S. Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- U.S. Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- U.S. Contraceptive Drugs Market, by Product
- Canada
- Canada Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Canada Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Canada Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Canada Contraceptive Drugs Market, by Product
-
Mexico
- Mexico Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Mexico Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Mexico Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Mexico Contraceptive Drugs Market, by Product
-
North America Contraceptive Drugs Market, by Product
- Europe
-
Europe Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
-
Europe Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
-
Europe Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- U. K.
- U.K. Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- U.K. Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- U.K. Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- U.K. Contraceptive Drugs Market, by Product
- France
- France Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- France Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- France Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- France Contraceptive Drugs Market, by Product
-
Germany
- Germany Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Germany Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Germany Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Germany Contraceptive Drugs Market, by Product
-
Italy
- Italy Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Italy Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Italy Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Italy Contraceptive Drugs Market, by Product
-
Spain
- Spain Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Spain Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Spain Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Spain Contraceptive Drugs Market, by Product
-
Rest of Europe
- Rest of Europe Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Rest of Europe Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Rest of Europe Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Rest of Europe Contraceptive Drugs Market, by Product
-
Europe Contraceptive Drugs Market, by Product
- Asia Pacific
-
Asia Pacific Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
-
Asia Pacific Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
-
Asia Pacific Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- China
- China Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- China Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- China Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- China Contraceptive Drugs Market, by Product
- Japan
- Japan Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Japan Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Japan Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Japan Contraceptive Drugs Market, by Product
-
Germany
- Germany Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Germany Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Germany Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Germany Contraceptive Drugs Market, by Product
-
India
- India Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- India Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- India Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- India Contraceptive Drugs Market, by Product
-
South Korea
- South Korea Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- South Korea Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- South Korea Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- South Korea Contraceptive Drugs Market, by Product
-
South East Asia
- South East Asia Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- South East Asia Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- South East Asia Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- South East Asia Contraceptive Drugs Market, by Product
-
Rest of Asia Pacific
- Rest of Asia Pacific Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Rest of Asia Pacific Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Rest of Asia Pacific Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Rest of Asia Pacific Contraceptive Drugs Market, by Product
-
Asia Pacific Contraceptive Drugs Market, by Product
- Latin America
-
Latin America Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
-
Latin America Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
-
Latin America Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Brazil
- Brazil Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Brazil Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Brazil Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Brazil Contraceptive Drugs Market, by Product
- Argentina
- Argentina Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Argentina Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Argentina Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Argentina Contraceptive Drugs Market, by Product
-
Rest of Latin America
- Rest of Latin America Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Rest of Latin America Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Rest of Latin America Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Rest of Latin America Contraceptive Drugs Market, by Product
-
Latin America Contraceptive Drugs Market, by Product
- Middle East & Africa
-
Middle East & Africa Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
-
Middle East & Africa Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
-
Middle East & Africa Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- GCC Countries
- GCC Countries Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- GCC Countries Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- GCC Countries Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- GCC Countries Contraceptive Drugs Market, by Product
- South Africa
- South Africa Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- South Africa Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- South Africa Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- South Africa Contraceptive Drugs Market, by Product
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Contraceptive Drugs Market, by Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Rest of Middle East & Africa Contraceptive Drugs Market, by Age Group
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Rest of Middle East & Africa Contraceptive Drugs Market, by End User
- Homecare
- Hospitals
- Clinics
- Rest of Middle East & Africa Contraceptive Drugs Market, by Product
-
Middle East & Africa Contraceptive Drugs Market, by Product
- North America
FAQ
Frequently Asked Question
What is the global demand for Contraceptive Drugs in terms of revenue?
-
The global Contraceptive Drugs valued at USD 12.62 Billion in 2022 and is expected to reach USD 18.94 Billion in 2030 growing at a CAGR of 5.20%.
Which are the prominent players in the market?
-
The prominent players in the market are Agile Therapeutics, Allergan PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 5.20% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Contraceptive Drugs include
- Rise in need for preventing unwanted pregnancy
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Contraceptive Drugs in 2022.